Company’s Banking Stock: Dissecting a -17.59% Quarterly Revenue Decline Amid Growth
The market performance of NeuroSense Therapeutics Ltd has been somewhat unstable. Over the past year, the company’s stock achieved a high of $2.33 on 03/01/24, with the lowest value for the same timeframe being $0.40, recorded on 10/24/23. 52-week price history of NRSN Stock Analyzing